TrialJournal of thrombosis and thrombolysis2014

The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery.

Vacis Tatarunas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.